NL-OMON40193Not yet recruitingPhase 4
The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioning. - mirtazapine, quetiapine and sleep
GGZ Drenthe (Assen)0 sites25 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Non-smoking, male, between the ages of 18 and 35 years.
Exclusion Criteria
- •Past or present sleeping disorder and/or psychiatric disorder, a family history of sleeping disorder and/or psychiatric disorder, liver disease, cardiovascular disease, alcohol- or substance dependence, medication use (including psychotropic medication), known intolerance for mirtazapine or quetiapine, a BMI of or below 18.5 or of or above 30.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioning.InsomniaEUCTR2013-003460-31-NLGGZ-Drenthe
Recruiting
Phase 3
Effect of Mirtazapine on aggression in patients with AlzheimerAlzheimer's diseaseIRCT20210613051565N1niversity of social welfare and rehabilitation sciences52
Recruiting
Phase 3
Effect of Mirtazapine on the quality of life of the breast cancer patientsIRCT20210425051075N1Sabzevar University of Medical Sciences110
Completed
Not Applicable
The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioningInsomniaISRCTN20011041GGZ Drenthe19
Not yet recruiting
Phase 3
Comparison of shivering in drugs of Mirtazapine , Dexamethasone and Tramadol after spinal anaesthesiaCTRI/2023/12/060608SRINIVASAN T